PSI Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-700
| Closed | – | – | 741 |
|
|
2025
Q1 | $0 | Hold |
700
| – | – | ﹤0.01% | 960 |
|
|
2024
Q4 | $0 | Hold |
700
| – | – | ﹤0.01% | 921 |
|
|
2024
Q3 | $13 | Hold |
700
| – | – | ﹤0.01% | 886 |
|
|
2024
Q2 | $75 | Buy |
+700
| New | +$335 | ﹤0.01% | 854 |
|
|
2024
Q1 | – | Sell |
-700
| Closed | -$1.23K | – | 868 |
|
|
2023
Q4 | $1.23K | Sell |
700
-495
| -41% | -$723 | ﹤0.01% | 748 |
|
|
2023
Q3 | $1.72K | Buy |
1,195
+140
| +13% | +$350 | ﹤0.01% | 694 |
|
|
2023
Q2 | $2.74K | Hold |
1,055
| – | – | ﹤0.01% | 642 |
|
|
2023
Q1 | $3.88K | Hold |
1,055
| – | – | ﹤0.01% | 560 |
|
|
2022
Q4 | $1.87K | Sell |
1,055
-300
| -22% | -$798 | ﹤0.01% | 613 |
|
|
2022
Q3 | $6K | Hold |
1,355
| – | – | ﹤0.01% | 510 |
|
|
2022
Q2 | $8K | Buy |
1,355
+700
| +107% | +$5.73K | ﹤0.01% | 515 |
|
|
2022
Q1 | $10K | Sell |
655
-700
| -52% | -$9.37K | ﹤0.01% | 476 |
|
|
2021
Q4 | $21K | Buy |
1,355
+185
| +16% | +$4.44K | 0.01% | 396 |
|
|
2021
Q3 | $37K | Buy |
+1,170
| New | +$41.1K | 0.02% | 314 |
|
Other funds holding DMTK
PSI Advisors's DMTK Position: Q2 2025 in Review
PSI Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2025, closing a stake of 700 shares.
PSI Advisors first reported a position in DMTK in Q3 2021 and held it in 14 quarters. The position peaked at $37K in Q3 2021. 2 funds tracked by Wall St. Rank hold DMTK as of Q2 2025.
- PSI Advisors reported no remaining DermTech, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- PSI Advisors sold 700 DermTech, Inc. Common Stock shares in Q2 2025.
- PSI Advisors first reported a position in DermTech, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
- PSI Advisors's DermTech, Inc. Common Stock position peaked at $37K in Q3 2021.
- 2 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2025.
Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.